Please assess the completion status of the following clinical trial:

Trial Title: Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* A clinical diagnosis of acne vulgaris with facial involvement.~* A minimum of 20 but not more than 50 inflammatory lesions~* A minimum of 30 but not more than 100 noninflammatory lesions~* A score of 3 (Moderate) on the Investigator's Global Assessment Scale

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Adapalene/Benzoyl Peroxide Gel (Type: EXPERIMENTAL): Participants were treated with adapalene 0.1 % \[weight by weight (W/W)\]/benzoyl peroxide 2.5 % (W/W) gel topically daily in the evening for 12 Weeks.
- Adapalene Gel, 0.1% (Type: EXPERIMENTAL): Participants were treated with 0.1% of adapalene gel topically daily in the evening for 12 Weeks.
- Benzoyl Peroxide Gel 2.5% (Type: EXPERIMENTAL): Participants were treated with 2.5% of benzoyl peroxide gel topically daily in the evening for 12 Weeks.
- Gel Vehicle (Type: PLACEBO_COMPARATOR): Participants were treated with gel vehicle topically daily in the evening for 12 Weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).